Chronic Diabetes Complications Bidirectionally Linked to Mental Health Disorders
By Lori Solomon HealthDay Reporter
WEDNESDAY, Aug. 28, 2024 -- There is a consistent, bidirectional association between chronic diabetes complications (CDCs) and mental health disorders (MHDs), according to a study published online July 15 in Diabetes Care.
Maya Watanabe, from the University of Michigan in Ann Arbor, and colleagues examined bidirectional associations between the timing of CDCs and MHDs in individuals with type 1 or type 2 diabetes. The analysis included 553,552 individuals (44,735 with type 1 diabetes, 152,187 with type 2 diabetes, and 356,630 without diabetes).
The researchers found that having a CDC increased the risk for developing an MHD (hazard ratio, 1.9 to 2.9), with a higher risk observed in older age strata. Furthermore, having an MHD increased the risk for developing a CDC (hazard ratio, 1.4 to 2.5), with a higher risk observed among those ages 0 to 19 years. In younger individuals (younger than 60 years), those with type 1 diabetes were more likely to have CDCs, while those with type 2 diabetes were more likely to have MHDs. However, the bidirectional relationship between CDCs and MHDs was not affected by diabetes type.
"Most likely, a combination of direct and indirect effects and shared risk factors drive the association we are seeing," Watanabe said in a statement. "Diabetes care providers may be able to simultaneously prevent the risk of multiple complications by providing interventions to treat these shared risk factors."
Several authors disclosed ties to the pharmaceutical and medical device industries.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
GLP-1 Receptor Agonist Use Linked to Lower Mortality in Seniors With Cancer, T2D
THURSDAY, July 24, 2025 -- For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause...
Alopecia Areata Associated With Severe Psychosocial Impact
THURSDAY, July 24, 2025 -- Alopecia areata (AA) has a severe psychosocial impact, which is linked to illness perceptions and stigma more strongly than disease severity, according...
Few School Principals Report District-Mandated Mental Health Screening
THURSDAY, July 24, 2025 -- Few school principals report district-mandated mental health screening in schools, according to a study published online July 18 in JAMA Network...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.